Ophthalmology Times - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic ...

At ARVO 2025, in Salt Lake City, Utah, Diana Do, MD, gave an update on the LIGHTSITE III study of photobiomodulation for dry age-related macular degeneration.

NCX 470, Nicox’s lead clinical product candidate, is a novel NO-donating bimatoprost eye drop with a dual mechanism of action ...

A recent analysis reveals that ellipsoidal zone-retinal pigment epithelial thickness predicts future visual loss in ...

A recent analysis reveals a strong link between photoreceptor health and visual function in geographic atrophy, emphasizing ...

Giullia Coradetti, MD, offered insight into her research on a post-hoc analysis based on the GATHER 2 clinical trial data for ...

Christina Prescott, MD, talks about the rate of recurrence of stromal keratitis in the Zoster Eye Disease Study, both in the ...

A recent study reveals how geographic atrophy affects patients' vision and quality of life, highlighting their coping ...

ARVO 2025: The first phase 2 study to examine tyrosine kinase inhibitors for wet AMD ...

(Part 1) From ophthalmology’s lockdown to lasting change: Five Aprils ago ...

(Part 1) From ophthalmology’s lockdown to lasting change: Five Aprils ago ...

(Part 1) From ophthalmology’s lockdown to lasting change: Five Aprils ago ...